Clinical Therapeutics

Editorial Comment
pp. 153-153(1)
Author: Walson P.D.

Cefaclor Revisited
pp. 154-166(13)
Author: Meyers B.R.

Antiglaucoma Medications: A Review of Safety and Tolerability Issues Related to Their Use
pp. 167-208(42)
Author: Schuman J.S.

Efficacy of Oral Long-Term N-Acetylcysteine in Chronic Bronchopulmonary Disease: A Meta-Analysis of Published Double-Blind, Placebo-Controlled Clinical Trials
pp. 209-221(13)
Authors: Grandjean E.M.; Berthet P.; Ruffmann R.; Leuenberger P.

Improved Postprandial Glycemic Control with Humalog⁽R) Mix75/25^TM After a Standard Test Meal in Patients with Type 2 Diabetes Mellitus
pp. 222-230(9)
Authors: Malone J.K.; Woodworth J.R.; Arora V.; Yang H.; Campaigne B.N.; Halle J.-P.; Yale J.-F.; Grossman L.D.

Effect on Bioavailability of Admixing the Contents of Lansoprazole Capsules with Selected Soft Foods
pp. 231-236(6)
Authors: Chun A.H.C.; Erdman K.; Zhang Y.; Achari R.; Cavanaugh J.H.

Use of Hydrofluoroalkane Propellant Delivery System for Inhaled Albuterol in Patients Receiving Asthma Medications
pp. 237-247(11)
Authors: Boccuzzi S.J.; Wogen J.; Roehm J.B.

Economic Assessment of the Community-Acquired Pneumonia Intervention Trial Employing Levofloxacin
pp. 250-264(15)
Authors: Palmer C.S.; Zhan C.; Elixhauser A.; Halpern M.T.; Rance L.; Feagan B.G.; Marrie T.J.